Zobrazeno 1 - 10
of 45
pro vyhledávání: '"N V Minaeva"'
Autor:
E N Parovichnikova, L A Kuzmina, L P Mendeleeva, G A Klyasova, V V Troitskaya, A N Sokolov, Z Kh Akhmerzaeva, S K Kravchenko, E O Gribanova, E E Zvonkov, S N Bondarenko, O Yu Baranova, T V Ryltsova, L V Gavrilova, E E Zinina, A S Pristupa, T S Kaporskaya, N V Minaeva, O S Samoilova, T S Konstantinova, V A Lapin, K D Kaplanov, I V Kryuchkova, A S Nizamutdinova, A V Klimovich, E A Borisenkova, V I Moskov, T V Gaponova, T V Obukhova, I V Galtseva, M A Rusinov, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 15-25 (2015)
Aim. To analyze the efficiency of the ALL-2009 protocol (ClinicalTrials.gov NCT01193933) in patients with T-cell leukemias, particularly the role of autologous hematopoietic stem cell transplantation (auto-HSCT) after non-myeloablative BEAM condition
Externí odkaz:
https://doaj.org/article/27ad8c10cab742848afc72addee75fae
Autor:
E. A. Poponina, A. O. Pestrikova, E. L. Nazarova, N. V. Isaeva, E. S. Fokina, A. I. Endakova, N. V. Minaeva
Publikováno v:
Медицинская иммунология, Vol 26, Iss 1, Pp 121-126 (2024)
Hematopoietic stem cell transplantation is used to treat hemoblastoses and some other diseases. Depending on the diagnosis, autologous cells of the patient or allogeneic cells obtained from a healthy related or unrelated donor are used. A sufficient
Externí odkaz:
https://doaj.org/article/12fbde7f1c524c32a786d5ab3a763f95
Real-world assessment of treatment multiple myeloma patients on the example of one hematology center
Autor:
A. S. Luchinin, N. V. Minaeva
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 29-37 (2023)
Relevance. Despite significant improvements in therapeutic options, patients with multiple myeloma (MM) experience a series of remissions and relapses requiring further lines of therapy, which requires the prescription of new lines of therapy. Method
Externí odkaz:
https://doaj.org/article/7ad068a84f354802a898ae910018861f
Autor:
O. A. Aleshina, I. V. Galtseva, E. S. Kotova, G. I. Isinova, T. N. Obukhova, V. N. Dvirnik, A. B. Sudarikov, M. E. Grishunina, O. S. Samoilova, K. D. Kaplanov, V. A. Lapin, S. N. Bondarenko, E. S. Fokina, N. V. Minaeva, T. S. Konstantinova, Yu. V. Sveshnikova, E. E. Zinina, A. S. Antipova, O. Yu. Baranova, E. A. Borisenkova, Yu. O. Davydova, N. M. Kapranov, S. M. Kulikov, Yu. A. Chabaeva, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 18, Iss 1, Pp 20-30 (2023)
Background. The effectiveness of therapy for acute T-lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL) has significantly improved over the past decades, including through the implementation of hematopoietic stem cell transplantation
Externí odkaz:
https://doaj.org/article/ae6ce0a734c64904adb16a244596e630
Autor:
V. V. Ptushkin, A. D. Kulagin, E. A. Lukina, I. L. Davydkin, T. S. Konstantinova, V. S. Shamrai, N. V. Minaeva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borozinets
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 77-84 (2020)
Currently, the main pathogenetic method for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) is the treatment with recombinant monoclonal antibodies that block the C5 component of the complement system. Eculizumab is the first biotechnologi
Externí odkaz:
https://doaj.org/article/c8727c8295774e18b3a446395b05b823
Autor:
E. N. Parovichnikova, O. A. Aleshina, V. V. Troitskaya, Yu. A. Chabaeva, A. N. Sokolov, G. A. Isinova, E. S. Kotova, Z. H. Akhmerzaeva, G. A. Klyasova, I. V. Galtseva, Yu. O. Davydova, L. A. Kuzmina, S. N. Bondarenko, O. Yu. Baranova, A. S. Antipova, O. S. Samoilova, M. E. Grishunina, K. D. Kaplanov, T. S. Kaporskaya, T. S. Konstantinova, Yu. V. Sveshnikova, E. A. Borisenkova, E. S. Fokina, N. V. Minaeva, E. E. Zinina, V. A. Lapin, E. O. Gribanova, E. E. Zvonkov, V. N. Dvirnyk, G. M. Galstyan, T. N. Obukhova, A. B. Sudarikov, S. M. Kulikov
Publikováno v:
Russian journal of hematology and transfusiology. 67:460-477
Introduction. Over the past 5 years, signifi cant progress has been achieved in the treatment of patients with Ph-negative acute lymphoblastic leukemia (ALL). Treatment results were compared between two protocols of the Russian multicenter studies «
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 94, Iss 2, Pp 57-62 (2018)
A case of Norwegian scabies is described in a patient of 19 years with a lesion of the scalp, face, trunk, upper and lower extremities that occurred against the background of acute lymphoblastic leukemia. A good effect was obtained from conducting et
Externí odkaz:
https://doaj.org/article/3a342b1c54a5403ab4f3dee056859396
Publikováno v:
Медицинская иммунология, Vol 20, Iss 4, Pp 523-534 (2018)
A number of studies have shown that distinct common variants of the genes controlling immune/inflammatory response may affect efficiency of chronic lymphocytic leukemia (CLL) treatment. In a recently published paper, we reported polymorphic variants
Externí odkaz:
https://doaj.org/article/f2f1c195fb17458a8d8790b7e319a455
Publikováno v:
Mechanics of Solids. 57:451-454
Publikováno v:
Mechanics of Solids. 57:286-291